{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: These findings suggest that helodermin - produced hypotension is partly attributable to the activation of glibenclamide - sensitive K + channels ( K ( ATP ) channels ) , which presumably exist on arterial smooth muscle cells .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| hypotension |\n| glibenclamide |\n| K (ATP) channels |\n\nNote:\n\n* Hypotension is a condition of low blood pressure.\n* Glibenclamide is a medication used to treat type 2 diabetes.\n* K (ATP) channels are a type of potassium channel that is sensitive to ATP (adenosine triphosphate) and plays a role in regulating blood pressure.\n\nTherefore, the \"Disease\" entities in the paragraph are:\n\n* Hypotension\n* Glibenclamide\n* K (ATP) channels"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Sure, here's the updated table with the valid entities that clearly refer to \"Disease\":\n\n| Disease |\n| --- |\n| hypotension |\n\nThe other mentioned entities, \"glibenclamide\" and \"K (ATP) channels\", are not directly related to disease, so they are not included in the table."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: These findings suggest that helodermin - produced hypotension is partly attributable to the activation of glibenclamide - sensitive K + channels ( K ( ATP ) channels ) , which presumably exist on arterial smooth muscle cells .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| helodermin |\n| glibenclamide |\n| K (ATP) channels |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "Sure, here are the valid chemical entities in the paragraph:\n\n| Chemical |\n| --- |\n| helodermin |\n| glibenclamide |\n\nThe mention of \"K (ATP) channels\" does not refer to a specific chemical entity, but rather a type of ion channel that is sensitive to ATP. Therefore, it has been excluded from the list."}
  ]
}